Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance

Lung cancer is treated with many conventional therapies, such as surgery, radiation, and chemotherapy. However, these therapies have multiple undesirable side effects. To bypass the side effects elicited by these conventional treatments, molecularly-targeted therapies are currently in use or under d...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrank, Zachary, Chhabra, Gagan, Lin, Leo, Iderzorig, Tsatsral, Osude, Chike, Khan, Nabiha, Kuckovic, Adijan, Singh, Sanjana, Miller, Rachel J., Puri, Neelu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071023/
https://www.ncbi.nlm.nih.gov/pubmed/29973561
http://dx.doi.org/10.3390/cancers10070224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071023/
https://www.ncbi.nlm.nih.gov/pubmed/29973561
http://dx.doi.org/10.3390/cancers10070224

Ejemplares similares